Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

18 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Use of an alpha lipoic, methylsulfonylmethane and bromelain dietary supplement (Opera®) for chemotherapy-induced peripheral neuropathy management, a prospective study.
Desideri I, Francolini G, Becherini C, Terziani F, Delli Paoli C, Olmetto E, Loi M, Perna M, Meattini I, Scotti V, Greto D, Bonomo P, Sulprizio S, Livi L. Desideri I, et al. Among authors: terziani f. Med Oncol. 2017 Mar;34(3):46. doi: 10.1007/s12032-017-0907-4. Epub 2017 Feb 15. Med Oncol. 2017. PMID: 28205185 Clinical Trial.
SAFE trial: an ongoing randomized clinical study to assess the role of cardiotoxicity prevention in breast cancer patients treated with anthracyclines with or without trastuzumab.
Meattini I, Curigliano G, Terziani F, Becherini C, Airoldi M, Allegrini G, Amoroso D, Barni S, Bengala C, Guarneri V, Marchetti P, Martella F, Piovano P, Vannini A, Desideri I, Tarquini R, Galanti G, Barletta G, Livi L. Meattini I, et al. Among authors: terziani f. Med Oncol. 2017 May;34(5):75. doi: 10.1007/s12032-017-0938-x. Epub 2017 Mar 31. Med Oncol. 2017. PMID: 28364270 Review.
Use of an alfa-lipoic, Methylsulfonylmethane, Boswellia serrata and Bromelain dietary supplement (OPERA®) for aromatase inhibitors-related arthralgia management (AIA): a prospective phase II trial (NCT04161833).
Desideri I, Lucidi S, Francolini G, Meattini I, Ciccone LP, Salvestrini V, Valzano M, Morelli I, Angelini L, Scotti V, Bonomo P, Greto D, Terziani F, Becherini C, Visani L, Livi L. Desideri I, et al. Among authors: terziani f. Med Oncol. 2022 Jun 6;39(8):113. doi: 10.1007/s12032-022-01723-x. Med Oncol. 2022. PMID: 35666314 Clinical Trial.
Benefit of ablative versus palliative-only radiotherapy in combination with nivolumab in patients affected by metastatic kidney and lung cancer.
Desideri I, Francolini G, Scotti V, Pezzulla D, Becherini C, Terziani F, Delli Paoli C, Olmetto E, Visani L, Meattini I, Greto D, Bonomo P, Loi M, Detti B, Livi L. Desideri I, et al. Among authors: terziani f. Clin Transl Oncol. 2019 Jul;21(7):933-938. doi: 10.1007/s12094-018-02005-7. Epub 2018 Dec 18. Clin Transl Oncol. 2019. PMID: 30565084
A PPAR gamma agonist protects against oral mucositis induced by irradiation in a murine model.
Mangoni M, Sottili M, Gerini C, Desideri I, Bastida C, Pallotta S, Castiglione F, Bonomo P, Meattini I, Greto D, Olmetto E, Terziani F, Becherini C, Delli Paoli C, Trombetta L, Loi M, Biti G, Livi L. Mangoni M, et al. Among authors: terziani f. Oral Oncol. 2017 Jan;64:52-58. doi: 10.1016/j.oraloncology.2016.11.018. Epub 2016 Dec 3. Oral Oncol. 2017. PMID: 28024724
Radiotherapy in the age of cancer immunology: Current concepts and future developments.
Loi M, Desideri I, Greto D, Mangoni M, Sottili M, Meattini I, Becherini C, Terziani F, Delli Paoli C, Olmetto E, Bonomo P, Livi L. Loi M, et al. Among authors: terziani f. Crit Rev Oncol Hematol. 2017 Apr;112:1-10. doi: 10.1016/j.critrevonc.2017.02.002. Epub 2017 Feb 7. Crit Rev Oncol Hematol. 2017. PMID: 28325250 Review.
Incidence of skin toxicity in squamous cell carcinoma of the head and neck treated with radiotherapy and cetuximab: A systematic review.
Bonomo P, Loi M, Desideri I, Olmetto E, Delli Paoli C, Terziani F, Greto D, Mangoni M, Scoccianti S, Simontacchi G, Francolini G, Meattini I, Caini S, Livi L. Bonomo P, et al. Among authors: terziani f. Crit Rev Oncol Hematol. 2017 Dec;120:98-110. doi: 10.1016/j.critrevonc.2017.10.011. Epub 2017 Oct 31. Crit Rev Oncol Hematol. 2017. PMID: 29198343 Review.
Safety of concurrent adjuvant radiotherapy and chemotherapy for locally advanced soft tissue sarcoma.
Greto D, Loi M, Saieva C, Muntoni C, Delli Paoli C, Becherini C, Ciabatti C, Perna M, Campanacci D, Terziani F, Beltrami G, Scoccianti G, Bonomo P, Meattini I, Desideri I, Simontacchi G, Mangoni M, Livi L. Greto D, et al. Among authors: terziani f. Tumori. 2018 Oct;104(5):322-329. doi: 10.1177/0300891618765565. Epub 2018 Apr 11. Tumori. 2018. PMID: 29714662
A matched cohort study of radio-chemotherapy versus radiotherapy alone in soft tissue sarcoma patients.
Greto D, Loi M, Terziani F, Visani L, Garlatti P, Lo Russo M, Teriaca A, Muntoni C, Delli Paoli C, Topulli J, Campanacci D, Beltrami G, Scoccianti G, Bonomo P, Desideri I, Francolini G, Livi L. Greto D, et al. Among authors: terziani f. Radiol Med. 2019 Apr;124(4):301-308. doi: 10.1007/s11547-018-0939-7. Epub 2018 Sep 12. Radiol Med. 2019. PMID: 30209796
Assessment of a guideline-based heart substructures delineation in left-sided breast cancer patients undergoing adjuvant radiotherapy : Quality assessment within a randomized phase III trial testing a cardioprotective treatment strategy (SAFE-2014).
Francolini G, Desideri I, Meattini I, Becherini C, Terziani F, Olmetto E, Delli Paoli C, Pezzulla D, Loi M, Bonomo P, Greto D, Calusi S, Casati M, Pallotta S, Livi L. Francolini G, et al. Among authors: terziani f. Strahlenther Onkol. 2019 Jan;195(1):43-51. doi: 10.1007/s00066-018-1388-x. Epub 2018 Nov 7. Strahlenther Onkol. 2019. PMID: 30406290 Clinical Trial. English.
18 results